Parental Hesitancy About Routine Childhood and Influenza Vaccinations: A National Survey.
Journal
Pediatrics
ISSN: 1098-4275
Titre abrégé: Pediatrics
Pays: United States
ID NLM: 0376422
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
accepted:
13
04
2020
pubmed:
17
6
2020
medline:
1
9
2020
entrez:
17
6
2020
Statut:
ppublish
Résumé
The World Health Organization has designated vaccine hesitancy as 1 of the 10 leading threats to global health, yet there is limited current national data on prevalence of hesitancy among US parents. Among a nationally representative sample of US parents, we aimed to (1) assess and compare prevalence of hesitancy and factors driving hesitancy for routine childhood and influenza vaccination and (2) examine associations between sociodemographic characteristics and hesitancy for routine childhood or influenza vaccination. In February 2019, we surveyed families with children using the largest online panel generating representative US samples. After weighting, we assessed hesitancy using a modified 5-point Vaccine Hesitancy Scale and labeled parents as hesitant if they scored >3. A total of 2176 of 4445 parents sampled completed the survey (response rate 49%). Hesitancy prevalence was 6.1% for routine childhood and 25.8% for influenza vaccines; 12% strongly and 27% somewhat agreed they had concerns about serious side effects of both routine childhood and influenza vaccines. A total of 70% strongly agreed that routine childhood vaccines are effective versus 26% for influenza vaccine ( Almost 1 in 15 US parents are hesitant about routine childhood vaccines, whereas >1 in 4 are hesitant about influenza vaccine. Furthermore, 1 in 8 parents are concerned about vaccine safety for both routine childhood and influenza vaccines, and only 1 in 4 believe influenza vaccine is effective. Vaccine hesitancy, particularly for influenza vaccine, is prevalent in the United States.
Sections du résumé
BACKGROUND AND OBJECTIVES
The World Health Organization has designated vaccine hesitancy as 1 of the 10 leading threats to global health, yet there is limited current national data on prevalence of hesitancy among US parents. Among a nationally representative sample of US parents, we aimed to (1) assess and compare prevalence of hesitancy and factors driving hesitancy for routine childhood and influenza vaccination and (2) examine associations between sociodemographic characteristics and hesitancy for routine childhood or influenza vaccination.
METHODS
In February 2019, we surveyed families with children using the largest online panel generating representative US samples. After weighting, we assessed hesitancy using a modified 5-point Vaccine Hesitancy Scale and labeled parents as hesitant if they scored >3.
RESULTS
A total of 2176 of 4445 parents sampled completed the survey (response rate 49%). Hesitancy prevalence was 6.1% for routine childhood and 25.8% for influenza vaccines; 12% strongly and 27% somewhat agreed they had concerns about serious side effects of both routine childhood and influenza vaccines. A total of 70% strongly agreed that routine childhood vaccines are effective versus 26% for influenza vaccine (
CONCLUSIONS
Almost 1 in 15 US parents are hesitant about routine childhood vaccines, whereas >1 in 4 are hesitant about influenza vaccine. Furthermore, 1 in 8 parents are concerned about vaccine safety for both routine childhood and influenza vaccines, and only 1 in 4 believe influenza vaccine is effective. Vaccine hesitancy, particularly for influenza vaccine, is prevalent in the United States.
Identifiants
pubmed: 32540985
pii: peds.2019-3852
doi: 10.1542/peds.2019-3852
pmc: PMC7329256
pii:
doi:
Substances chimiques
Influenza Vaccines
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : R01 AI114903
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2020 by the American Academy of Pediatrics.
Déclaration de conflit d'intérêts
POTENTIAL CONFLICT OF INTEREST: Dr Zimet received an honorarium from Sanofi Pasteur for work on the Adolescent Immunization Initiative and consulting fees and travel support from Merck related to human papillomavirus vaccination; Dr Humiston received an honorarium from Sanofi Pasteur for work on the Clinical Immunization Collaborative Virtual Advisory Board; the other authors have indicated they have no potential conflicts of interest to disclose.
Références
Pediatrics. 2004 Jul;114(1):187-95
pubmed: 15231927
Health Promot Pract. 2017 Sep;18(5):654-661
pubmed: 28398837
Prev Med. 2013 Mar;56(3-4):202-6
pubmed: 23295175
Acad Pediatr. 2018 Mar;18(2):154-160
pubmed: 28826731
J Infect Dis. 2009 Jan 15;199(2):159-67
pubmed: 19086915
Pediatrics. 2013 Dec;132(6):1037-46
pubmed: 24190677
Pediatr Infect Dis J. 2005 Nov;24(11):974-8
pubmed: 16282932
Soc Sci Med. 2019 Nov;241:112205
pubmed: 31387766
J Gen Intern Med. 2019 Nov;34(11):2505-2511
pubmed: 31452036
Am J Prev Med. 2006 Sep;31(3):244-51
pubmed: 16905036
N Engl J Med. 2006 Jul 6;355(1):31-40
pubmed: 16822994
Pediatrics. 2012 Jun;129(6):1056-63
pubmed: 22566425
Public Health Rep. 2013 Jan-Feb;128(1):37-45
pubmed: 23277658
Pediatrics. 2008 Oct;122(4):718-25
pubmed: 18829793
Vaccine. 2018 Mar 27;36(14):1801-1803
pubmed: 29506923
Am J Public Health. 1981 Mar;71(3):270-4
pubmed: 7468859
MMWR Recomm Rep. 2016 Aug 26;65(5):1-54
pubmed: 27560619
Pediatrics. 2017 Jan;139(1):
pubmed: 27940512
Vaccine. 2019 Apr 24;37(18):2494-2501
pubmed: 30940484
Pediatrics. 2013 Jul;132(1):37-43
pubmed: 23733795
J Sex Med. 2019 Aug;16(8):1170-1177
pubmed: 31303571
J Sex Marital Ther. 2019;45(5):424-439
pubmed: 30946623
Am J Prev Med. 2015 Dec;49(6 Suppl 4):S391-8
pubmed: 26337116
JAMA. 2006 Oct 11;296(14):1757-63
pubmed: 17032989
Pediatrics. 2016 Sep;138(3):
pubmed: 27573088
Arch Sex Behav. 2019 Nov;48(8):2461-2472
pubmed: 31502071
N Engl J Med. 2012 Nov;367(18):1704-13
pubmed: 23113481
PLoS One. 2019 Oct 4;14(10):e0222577
pubmed: 31584957
Am J Public Health. 2018 Oct;108(10):1421-1423
pubmed: 30024803
Clin Pediatr (Phila). 2016 Jun;55(6):537-42
pubmed: 26581360
Vaccine. 2015 Feb 25;33(9):1223-9
pubmed: 25448095
JAMA Netw Open. 2019 Jan 4;2(1):e187355
pubmed: 30681707
Vaccine. 2015 Apr 8;33(15):1802-7
pubmed: 25744225
J Infect Dis. 2002 Jan 15;185(2):147-52
pubmed: 11807687
Pediatrics. 2019 Jun;143(6):
pubmed: 31113831
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Public Health Rep. 2017 Jul/Aug;132(4):451-454
pubmed: 28586623
JAMA. 2000 Dec 27;284(24):3145-50
pubmed: 11135778
Semin Pediatr Infect Dis. 2003 Jul;14(3):207-12
pubmed: 12913833
Am J Prev Med. 2018 Jul;55(1):44-54
pubmed: 29773490
JAMA Intern Med. 2019 Sep 16;:
pubmed: 31524938
Vaccine. 2018 Aug 23;36(35):5273-5281
pubmed: 30061026
Curr Opin Pediatr. 2020 Feb;32(1):151-159
pubmed: 31790027
Clin Infect Dis. 2012 May;54(10):1427-36
pubmed: 22495079
JAMA Pediatr. 2018 May 7;172(5):e180016
pubmed: 29507952
JAMA Pediatr. 2013 Nov;167(11):1065-71
pubmed: 24061681
Vaccine. 2011 Sep 2;29(38):6598-605
pubmed: 21763384
Pediatrics. 2017 Dec;140(6):
pubmed: 29109107
Vaccine. 2018 Jan 29;36(5):660-667
pubmed: 29289384
Vaccine. 2014 Apr 17;32(19):2150-9
pubmed: 24598724
JAMA. 2016 Mar 15;315(11):1149-58
pubmed: 26978210
Can Commun Dis Rep. 2013 Oct 30;39(ACS-3):1-52
pubmed: 31696866
J Gen Intern Med. 2019 Nov;34(11):2512-2519
pubmed: 31452029
Am J Public Health. 2015 Oct;105(10):1998-2004
pubmed: 25790386
Acad Pediatr. 2018 May - Jun;18(4):430-436
pubmed: 29325912
JAMA Cardiol. 2019 Nov 17;:
pubmed: 31734700
Pediatrics. 2010 Apr;125(4):654-9
pubmed: 20194286
Can Commun Dis Rep. 2016 Jul 07;42(7):139-145
pubmed: 29770019
Hum Vaccin. 2011 Apr;7(4):419-25
pubmed: 21389777
Vaccine. 2015 Aug 14;33(34):4165-75
pubmed: 25896384
MMWR Recomm Rep. 2019 Aug 23;68(3):1-21
pubmed: 31441906
PLoS Med. 2016 Mar 24;13(3):e1001977
pubmed: 27011229
Pediatrics. 2004 Mar;113(3 Pt 1):585-93
pubmed: 14993554
EBioMedicine. 2016 Oct;12:295-301
pubmed: 27658738
Hosp Pediatr. 2018 Oct;8(10):628-635
pubmed: 30228245
Vaccine. 2005 Apr 27;23(23):3053-60
pubmed: 15811652
J Infect Public Health. 2018 Mar - Apr;11(2):153-155
pubmed: 28988775
Public Health Rep. 2004 Mar-Apr;119(2):163-9
pubmed: 15192903
Psychol Sci Public Interest. 2017 Dec;18(3):149-207
pubmed: 29611455
N Engl J Med. 2009 May 7;360(19):1981-8
pubmed: 19420367
JAMA. 2004 Sep 15;292(11):1333-40
pubmed: 15367555
Open Forum Infect Dis. 2017 Nov 15;5(2):ofx244
pubmed: 29423420
Prev Med. 2018 Nov;116:203-210
pubmed: 30267734
Medicina (Kaunas). 2019 Jun 17;55(6):
pubmed: 31213037
Pediatr Ann. 2015 Apr;44(4):e76-81
pubmed: 25875983
JAMA. 1994 Oct 12;272(14):1127-32
pubmed: 7933326
Pediatrics. 2017 Oct;140(4):
pubmed: 28870977
J Infect Dis. 2008 Mar 1;197 Suppl 2:S76-81
pubmed: 18419414
Am J Public Health. 2016 Feb;106(2):273-8
pubmed: 26691123
Public Health Rep. 2011 Jul-Aug;126 Suppl 2:135-46
pubmed: 21812176
Clin Infect Dis. 2016 Dec 15;63(12):1564-1573
pubmed: 27702768
Pediatrics. 2008 Mar;121(3):e547-52
pubmed: 18310176
Pediatrics. 2011 May;127 Suppl 1:S92-9
pubmed: 21502253
MMWR Morb Mortal Wkly Rep. 2015 Jan 16;64(1):10-5
pubmed: 25590680
Public Health Rep. 2010 Jul-Aug;125(4):534-41
pubmed: 20597453
JAMA. 2003 Jan 8;289(2):179-86
pubmed: 12517228
MMWR Morb Mortal Wkly Rep. 2012 Dec 7;61(48):986-9
pubmed: 23222373